Form Type: 4

SEC EDGAR Link
Accession Number:0001714899-23-000055
Date:2023-04-12
Issuer: DENALI THERAPEUTICS INC. (DNLI)
Original Submission Date:

Reporting Person:

SCHUTH ALEXANDER O.
C/O DENALI THERAPEUTICS INC.
161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-04-12 M 5,102 a $5.28 533,793 indirect
COMMON STOCK 2023-04-12 S 5,102 d $25.04 528,691 indirect
COMMON STOCK 2023-04-13 M 4,898 a $5.28 533,589 indirect
COMMON STOCK 2023-04-13 S 4,898 d $25.04 528,691 indirect
COMMON STOCK 2023-04-12 0 $0.00 130,792 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 5.28 2023-04-12 deemed execution date M 5,102 (d) 2027-03-07 common stock 5,102 $5.28 93,835 direct
STOCK OPTION (RIGHT TO BUY) 5.28 2023-04-13 deemed execution date M 4,898 (d) 2027-03-07 common stock 4,898 $5.28 88,937 direct
Footnotes
IDfootnote
f1 exercised shares were issued to the schuth family trust.
f2 the shares are held of record by the schuth family trust u/a dtd 06/05/2017, for which the reporting person serves as trustee.
f3 the sales reported by the reporting person were affected pursuant to a rule 10b5-1 trading plan adopted september 30, 2022.
f4 the sale price reported in column 4 of table i represents the weighted average sale price of the shares ranging from $25.00 to $25.49 per share. upon request by the commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
f5 the sale price reported in column 4 of table i represents the weighted average sale price of the shares ranging from $25.00 to $25.10 per share. upon request by the commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
f6 includes 119,156 rsus.
f7 25% of the shares subject to the option vested on march 8, 2018 and an additional 1/48 of the shares vested monthly thereafter.
WhaleWisdom Logo

Elevate your investments